TF and prostate carcinoma: Wang et al. used transferrin as a drug carrier in loading IR780 iodide to form Tf-IR780 NPs, which have a high binding affinity with the transferrin receptor (TfR) overexpressed in various human tumors including breast and prostate cancer.